pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Cell Therapy · news · pharmadog
← back to Cell Therapy
News · Cell Therapy
309
stories
28d
Q&A: Bristol Myers' Lynelle Hoch on autoimmune CAR-T safety challenges
endpoints
28d
BMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trial
biospace
28d
BMS sheds light on patient death in CAR-T trial, wants to get program back on track
fiercebiotech
28d
Bristol Myers reveals death in MS CAR-T trial, has answer for safety signal in lupus trial
endpoints
29d
Chutes & Ladders—Troubled CSL enlists GSK vet Deborah Waterhouse to lead
fiercebiotech
29d
Biotech notches 31 IPOs already this year, with 4 more joining queue
biospace
29d
Why investors are taking another look at kidney disease
biospace
29d
Roche’s CEO has ‘absolutely not’ changed tune on Poseida despite scrapping CAR-T from the buyout
fiercebiotech
Oct 21, 26
Nigeria identifies travel-related Ebola case
stat
Oct 21, 26
STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved
stat
Oct 19, 26
Novartis ends mid-stage Fabhalta study in lupus, insists no efficacy or safety issues
biospace
Oct 19, 26
From strategy to scale: How Saudi Arabia is building a biotech ecosystem
biopharma dive
Oct 19, 26
More arms, more questions: The new challenge in multispecific drug design
biospace
Oct 16, 26
iPSCs come of age, powering breakthroughs in the lab and clinic
biospace
Oct 15, 26
Belgian startup revives Galapagos CAR-T research
biopharma dive
Oct 15, 26
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
biospace
Oct 15, 26
Paul Stoffels to bring Galapagos’ cell therapies back to life
endpoints
Oct 15, 26
Rebranded Galapagos finally finds buyer for unwanted cell therapy pipeline
fiercebiotech
Oct 15, 26
Iambic, an AI drug discovery specialist, banks $150M in an IPO
biopharma dive
Oct 13, 26
Another Paragon spinout goes public through reverse merger
biopharma dive
Oct 12, 26
Parkinson’s cell therapy developer files to go public
biopharma dive
Oct 10, 26
Parkinson’s-focused Aspen and bispecific biotech Bambusa plan IPOs
fiercebiotech
Oct 9, 26
Parkinson's cell therapy biotech Aspen and I&I startup Bambusa file for IPOs
endpoints
Oct 8, 26
In the hunt for reverse merger targets, Caribou could be prized game
biopharma dive
Oct 7, 26
Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
biopharma dive
Oct 7, 26
Updated: CAR-T biotech Caribou to pull the plug after struggling to find funding
endpoints
Oct 7, 26
iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa
fiercebiotech
Oct 6, 26
CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline
fiercebiotech
Oct 6, 26
MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’
fiercebiotech
Oct 6, 26
The top biopharma conferences in 2027
biopharma dive
← prev
page 3 of 11
next →